Probiotics for Digestive Health: Where They Help and Do Not

← Patient Education

Probiotics for digestive health are one of the most common questions we hear, usually from someone who has already bought a bottle and wants to know whether it is doing anything. The short version from gastroenterology guidelines is narrower than the store shelf suggests: for most digestive conditions in adults, the American Gastroenterological Association recommends probiotics only in the context of a clinical trial, or advises against them, and the clearest supported use is a specific situation after ulcerative colitis surgery. This page goes condition by condition through what the AGA and the American College of Gastroenterology actually say, for adults in Arlington, Annandale, and the rest of Northern Virginia who want a straight answer before spending more money.

This article is general education, not medical advice. If you take a probiotic or are thinking about one, talk it over with the clinician who knows your history, especially if you have a serious illness or a weakened immune system.

What probiotics are

The National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health, defines probiotics as live microorganisms that are intended to have health benefits when consumed or applied to the body. Its consumer page, Probiotics: Usefulness and Safety, notes that they are found in yogurt and other fermented foods, dietary supplements, and beauty products. The most common are bacteria from the Lactobacillus and Bifidobacterium groups, and some products contain a yeast, Saccharomyces boulardii.

Two related terms show up on labels. NCCIH describes prebiotics as nondigestible food components that selectively stimulate the growth or activity of desirable microorganisms, and synbiotics as products that combine a probiotic and a prebiotic.

The most useful point on that page for anyone shopping is about strains. NCCIH explains that different types of probiotics may have different effects: if one specific kind of Lactobacillus helps prevent an illness, that does not mean another kind of Lactobacillus, or any Bifidobacterium, would do the same thing. Guidelines are written the same way. When a society supports a probiotic for a condition, it names particular strains or combinations, and that support does not carry over to probiotics in general.

How probiotics for digestive health are regulated

According to NCCIH, the FDA may regulate a probiotic as a dietary supplement, a food ingredient, or a drug, depending on its intended use. Many probiotics are sold as dietary supplements, which do not require FDA approval before they are marketed. Supplement labels may make claims about how a product affects the structure or function of the body, but they are not allowed to make health claims, such as saying the supplement lowers your risk of a disease, without the FDA's consent. A probiotic marketed as a drug to treat a disease has to be proven safe and effective in clinical trials and approved by the FDA first.

That distinction matters in practice. A phrase like "supports digestive health" on a supplement label is a structure or function claim, not evidence that the product treats a digestive condition. NCCIH also reports that some probiotic products have been found to contain microorganisms other than those listed on the label.

The AGA guideline on probiotics for digestive health

The main source for this page is the AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders, published in Gastroenterology in June 2020 (doi.org/10.1053/j.gastro.2020.05.059). It covers C. difficile infection, adults and children on antibiotics, Crohn's disease, ulcerative colitis, pouchitis, irritable bowel syndrome, acute infectious gastroenteritis in children, and preterm infants. As of November 2026, the AGA still lists it as its probiotics guideline, and a PubMed search turned up no newer probiotics guideline from a US gastroenterology society.

Several of its eight recommendations use a specific phrase: probiotics are recommended "only in the context of a clinical trial." That is the guideline's way of saying the evidence is not strong enough to recommend them in routine care, and that the open question belongs in research studies, not in everyday treatment. Newer AGA documents on individual conditions have since added to the 2020 guideline, and in one case, C. diff, have moved past it. Each section below says which document it relies on.

Probiotics for IBS

Irritable bowel syndrome is where probiotics are marketed most heavily, and where the guidance is most consistently cautious. The 2020 AGA guideline recommends probiotics for symptomatic children and adults with IBS only in the context of a clinical trial.

The ACG Clinical Guideline on the Management of Irritable Bowel Syndrome (American Journal of Gastroenterology, 2021) reaches a similar place. It suggests against probiotics for the treatment of global IBS symptoms, as a conditional recommendation based on a very low level of evidence. The ACG explains why the research is hard to read: there are many probiotic products, studies have tested single strains and multi-strain mixtures, most trials are small and single-center, the benefits on individual symptoms are inconsistent, and few trials meet the endpoint standards the FDA uses to approve medications. It calls probiotics an important area of research, given the role of the gut microbiome in IBS.

The same ACG guideline does recommend a limited trial of a low FODMAP diet to improve global IBS symptoms, along with several prescription options and gut-directed psychotherapy. Our pages on IBS and the low FODMAP diet explain those approaches.

Probiotics for bloating and gas

Bloating is one of the main reasons people try a probiotic. The AGA's 2023 clinical practice update on belching, abdominal bloating, and distention is direct: its tenth statement says probiotics should not be used to treat abdominal bloating and distention.

The ACG's IBS guideline adds a related observation. In the meta-analysis it reviewed, no category of probiotic showed a benefit for bloating in pooled analysis. If bloating is your main symptom, our page on chronic bloating and gas covers the causes a gastroenterologist looks for, including food intolerances and small intestinal bacterial overgrowth.

Probiotics with antibiotics and C. diff

This is the area where AGA guidance has changed, and where older articles online are most likely to be out of date.

The 2020 guideline made two separate points. For people who already have a C. difficile infection, it recommended probiotics only in the context of a clinical trial. For adults and children taking antibiotics, it suggested certain probiotics (Saccharomyces boulardii, or one of three named multi-strain Lactobacillus and Bifidobacterium combinations) over no probiotic to prevent C. diff infection. That second recommendation was conditional, not strong.

The AGA's newer clinical practice update on C. difficile infection in adults, published June 30, 2026, takes a different position. It states that probiotics are not advised to prevent an initial or recurrent C. diff infection. To support a healthy gut microbiome, it advises a healthy diet that includes a variety of fruits and vegetables rich in both soluble and insoluble fiber. Because the 2026 update is the more recent AGA document on this question, this page follows it. If a clinician has recommended a probiotic for you during an antibiotic course, it is reasonable to ask how that fits with the newer AGA advice.

For recurrent C. diff, the 2026 update does support microbiome-based treatment, but not through supplements. It describes FDA-approved fecal microbiota products (fecal microbiota spores, live-brpk, sold as Vowst, and fecal microbiota, live-jslm, sold as Rebyota) and conventional fecal microbiota transplant, which should be offered after treatment of a second recurrence. These are regulated therapies used under a clinician's care, not over-the-counter probiotics. Our C. diff infection page covers testing, treatment, and prevention in more detail.

Probiotics for Crohn's disease and ulcerative colitis

For inflammatory bowel disease itself, the 2020 AGA guideline recommends probiotics in adults and children with Crohn's disease only in the context of a clinical trial, and makes the same recommendation for ulcerative colitis.

That matters because people with IBD sometimes hope a probiotic can replace or delay a prescribed medication. Nothing in the AGA guidance supports that. Crohn's disease and ulcerative colitis are treated with medications that control inflammation, and stopping or delaying them can allow the disease to flare. Our pages on Crohn's disease and ulcerative colitis and on diet and IBD explain what the evidence does support.

Pouchitis after ulcerative colitis surgery

The clearest supported use of probiotics for digestive health in adults is a narrow one. Some people with ulcerative colitis have surgery to remove the colon and create an internal pouch from the small intestine, called an ileal pouch-anal anastomosis (IPAA). Inflammation of that pouch is called pouchitis.

The 2020 AGA guideline suggested a specific eight-strain combination of Lactobacillus, Bifidobacterium, and Streptococcus strains for pouchitis over no probiotic or other probiotics. The AGA's later guideline on pouchitis and inflammatory pouch disorders, published December 19, 2023, is more precise about when:

• Preventing a first episode after surgery: the AGA makes no recommendation for or against probiotics.
• Treating infrequent episodes of pouchitis: the AGA makes no recommendation for or against probiotics, and suggests antibiotics for treatment.
• Recurrent pouchitis that responds to antibiotics: the AGA suggests using probiotics to prevent further recurrences.

Pouchitis management is specialist care. If you have a pouch and repeated flares, the decision about probiotics belongs with the gastroenterologist or colorectal surgeon who manages it.

Probiotics for diverticulitis

The AGA has addressed diverticulitis twice. Its 2015 guideline on acute diverticulitis suggests against the use of probiotics after acute uncomplicated diverticulitis. Its 2020 clinical practice update on medical management of colonic diverticulitis states that people with a history of diverticulitis should not be treated with mesalamine, probiotics, or rifaximin to prevent recurrent diverticulitis. Our page on diverticulitis and diverticulosis covers what does lower the risk of another episode.

Other uses of probiotics for digestive health

Probiotics also come up in conditions other gastroenterology documents have covered:

• H. pylori: the AGA's 2021 clinical practice update on refractory H. pylori infection states that proposed add-on therapies, including probiotics, are of unproven benefit as treatment. Our peptic ulcers and H. pylori page covers standard treatment.
• Long-term acid-reducing medication: as our long-term PPI use page explains, the AGA's 2017 review of proton pump inhibitor risks advised against routinely taking probiotics to prevent infection while on a PPI.
• Microscopic colitis: both the AGA and European guidelines recommend against probiotics for treating it, as our microscopic colitis page describes.
• SIBO: the ACG guideline notes a lack of consistent data supporting any specific probiotic for treating small intestinal bacterial overgrowth.
• Stomach flu in children: the 2020 AGA guideline suggests against probiotics for children with acute infectious gastroenteritis.

Are probiotics for digestive health safe?

NCCIH says probiotics have an extensive history of apparently safe use, particularly in healthy people, but that few studies have looked at safety in detail, so there is a lack of solid information on how often side effects happen and how severe they are. The risk of harm is greater in people with severe illnesses or weakened immune systems. NCCIH lists possible harms as infections, production of harmful substances by the probiotic microorganisms, and transfer of antibiotic resistance genes to other organisms in the gut.

NCCIH also notes that severe or fatal infections have been reported in premature infants given probiotics, and that the FDA has warned health care providers about this risk. That warning concerns hospitalized preterm infants, not healthy adults, but it is a reminder that "natural" and "harmless" are not the same thing.

Two pieces of NCCIH's advice are worth repeating. If you are considering a probiotic supplement, check with your health care provider first, especially if you have health problems, and anyone with a serious underlying condition should be monitored closely while taking one. And do not use probiotics as a reason to put off seeing a clinician about a health problem.

Making a decision about probiotics for digestive health

If you already take a probiotic and feel well, there is no reason for alarm. The guidelines above are about whether the evidence supports recommending probiotics, not a finding that they hurt most healthy people. A few practical points follow from the guidance:

• Bring every supplement to your visit, including probiotics. Some tests and treatments are affected by recent supplement or antibiotic use, and your gastroenterologist needs the full list.
• A probiotic is not a substitute for evaluating persistent symptoms. Ongoing diarrhea, bloating, or abdominal pain has causes that can be tested for, including celiac disease, microscopic colitis, and IBD.
• If a clinician does recommend a probiotic for a specific reason, ask which strain or combination, for how long, and what result you should expect. Support for one product does not carry over to another.
• Do not stop or delay a prescribed medication for IBD, C. diff, or any other condition in favor of a probiotic without talking to the prescribing clinician.

Symptoms that should not wait

Some digestive symptoms need prompt evaluation whatever you are taking. Contact your doctor for blood in the stool, black or tarry stools, diarrhea that wakes you at night, weight loss you cannot explain, fever with diarrhea, or severe diarrhea during or after an antibiotic course. Our pages on chronic diarrhea and blood in the stool explain more. Severe abdominal pain, heavy bleeding, fainting, or signs of dehydration are an emergency: call 911 or go to an emergency department.

Digestive care in Northern Virginia with GC of NoVA

Gastroenterology Center of Northern Virginia cares for adults across Arlington, Annandale, and the surrounding communities. Our five gastroenterologists evaluate persistent digestive symptoms, test for the conditions that commonly sit behind them, and talk through where supplements such as probiotics do and do not fit, using current AGA and ACG guidance. Our page on your first gastroenterologist visit explains what to bring, including a list of supplements, and our page on when to see a gastroenterologist can help you decide whether it is time.

We see patients at our Arlington office at 1715 N George Mason Drive, adjacent to VHC Health, and our Annandale office at 3299 Woodburn Road in the Woodburn Medical complex. To schedule a visit, call Arlington at (703) 522-7476 or Annandale at (703) 560-6106, or learn more at gcofnova.com.

This article is for general education and is not medical advice. Talk with a qualified gastroenterologist about your symptoms, diagnosis, and treatment options.